Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Valeant Received Upfront Payment From GSK

By Pharmaceutical Processing | October 20, 2008

ALISO VIEJO, Calif. (AP) Valeant Pharmaceuticals International said Friday it received an upfront payment of $125 million for a collaboration with GlaxoSmithKline to develop a new epilepsy treatment. In August, Valeant announced the deal, which includes its late-stage development drug retigabine. The company is also eligible to receive up to $825 million under the deal. If retigabine proceeds through regulatory approval and reaches the market, GlaxoSmithKline will pay Valeant up to $545 million. Valeant could receive up to $150 million for the development and sales of another drug candidate, VRX698. Valeant will receive half the net profits from sales of retigabine in the U.S., Canada, Australia, New Zealand and Puerto Rico, and will receive a 20 percent royalty on sales in other countries. The companies plan to seek Food and Drug Administration approval and European marketing approval by early 2009.

Related Articles Read More >

FDA logo
FDA prevented 317 drug shortages in 2021
Pfizer-BioNTech vaccine vial
Pfizer, BioNTech moving forward on seeking COVID-19 vaccine EUA for youngest children
FDA logo
FDA curtails use of Janssen COVID-19 vaccine over blood clotting concerns
FDA logo
FDA sends warning letters to CBD and delta-8 THC product vendors

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards